Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Slivjak

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Pharmacology|June 1, 1990
SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious ratE F Smith, M J Slivjak, J W Egan, et al.
Progress in Clinical and Biological Research|January 1, 1989
Inhibition of peptidoleukotriene responses does not moderate ischemic damage or neutrophil infiltration in myocardium following coronary artery occlusion with reperfusionE F Smith, J W Egan, L M Hillegass, et al.
Pharmacology|March 1, 1994
Endotoxin-mediated changes in plasma endothelin concentrations, renal endothelin receptor and renal functionP Nambi, M Pullen, M J Slivjak, et al.
European Journal of Pharmacology|June 20, 1989
Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shockP H Lento, K Saukkonen, N Aoki, et al.
Pharmacology|May 1, 1993
Fluid resuscitation improves survival of endotoxemic or septicemic rats: possible contribution of tumor necrosis factorE F Smith, M J Slivjak, J W Egan, et al.
Pharmacology|January 1, 1992
Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the ratE F Smith, D E Griswold, L M Hillegass, et al.
International Journal of Immunopharmacology|October 1, 1994
Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitorU Prabhakar, D Lipshutz, J O Bartus, et al.
Prostaglandins|May 1, 1989
Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusionJ W Egan, D E Griswold, L M Hillegass, et al.
Thrombosis Research|May 15, 1992
Pharmacological profile of G619, a new platelet aggregation inhibitorT L Yue, E F Smith, E H Ohlstein, et al.
Journal of Cardiovascular Pharmacology|November 1, 1991
Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinaseE F Smith, A J Nichols, T S Sellers, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Pharmacology|June 1, 1990
SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious ratE F Smith, M J Slivjak, J W Egan, et al.
Progress in Clinical and Biological Research|January 1, 1989
Inhibition of peptidoleukotriene responses does not moderate ischemic damage or neutrophil infiltration in myocardium following coronary artery occlusion with reperfusionE F Smith, J W Egan, L M Hillegass, et al.
Pharmacology|March 1, 1994
Endotoxin-mediated changes in plasma endothelin concentrations, renal endothelin receptor and renal functionP Nambi, M Pullen, M J Slivjak, et al.
European Journal of Pharmacology|June 20, 1989
Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shockP H Lento, K Saukkonen, N Aoki, et al.
Pharmacology|May 1, 1993
Fluid resuscitation improves survival of endotoxemic or septicemic rats: possible contribution of tumor necrosis factorE F Smith, M J Slivjak, J W Egan, et al.
Pharmacology|January 1, 1992
Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the ratE F Smith, D E Griswold, L M Hillegass, et al.
International Journal of Immunopharmacology|October 1, 1994
Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitorU Prabhakar, D Lipshutz, J O Bartus, et al.
Prostaglandins|May 1, 1989
Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusionJ W Egan, D E Griswold, L M Hillegass, et al.
Thrombosis Research|May 15, 1992
Pharmacological profile of G619, a new platelet aggregation inhibitorT L Yue, E F Smith, E H Ohlstein, et al.
Journal of Cardiovascular Pharmacology|November 1, 1991
Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinaseE F Smith, A J Nichols, T S Sellers, et al.
Pageof 2